ISS ESG InFocus: Pharmaceuticals & Biotechnology
ISS ESG’s team of specialist analysts release regular updates on the ESG risks associated with a specific industry. The InFocus reports focus on the ISS
ISS ESG’s team of specialist analysts release regular updates on the ESG risks associated with a specific industry. The InFocus reports focus on the ISS
Below is an excerpt from ISS ESG’s recently released paper “Cruelty-Free Portfolios: How To Approach Animal Testing In Investments?”. The full paper is available for